Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result

Liver International

Volumn 27, Issue 4, 2007, Pages 516-528

  Liang, Po Chin ^a   Ch'ang, Hui Ju ^b   Hsu, Chiun ^a   Tseng, Shuo Shuo ^a   Shih, Tiffany T F ^a,c   Wu Liu, Tsang ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Dynamic contrast enhanced magnetic resonance imaging; Hepatocellular carcinoma; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RADIATION DOSE; SIGNAL PROCESSING; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 34047204089     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01456.x     Document Type: Article

References (48)

1. Lin TM, Tsu WT, Chen CJ. Mortality of hepatoma and cirrhosis of liver in Taiwan. Br J Cancer 1986; 54(6): 969-76.
2. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989; 124(9): 1025-8.
3. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model. Cancer 1991; 68(10): 2150-4.
4. Hsu C, Cheng JC, Cheng AL. Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. J Formos Med Assoc 2004; 103(7): 483-95.
5. Stillwagon GB, Order SE, Guse C, et al. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: Toxicity and response: A radiation therapy oncology group study. Int J Radiat Oncol Biol Phys 1989; 17(6): 1223-9.
6. Lawrence TS, Dworzanin LM, Walker-Andrews SC, et al. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys 1991; 20(3): 555-61.
7. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18(11): 2210-8.
8. Lawrence TS, Tesser RJ, ten Haken RK. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 1990; 19(4): 1041-7.
9. Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992; 23(4): 781-8.
10. McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998; 16(6): 2246-52.
11. Seong J, Park HC, Han KH, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000; 47(5): 1331-5.
12. Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2000; 47(2): 435-42.
13. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 2001; 19(1): 164-70.
14. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: Unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999; 91(6): 523-8.
15. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005; 102(15): 5524-9.
16. Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2003; 57(1): 113-9.
17. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 2001; 61(5): 2207-11.
18. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229(2): 409-14.
19. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47(1): 135-42.
20. Mayr NA, Yuh WT, Magnotta VA, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: A new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996; 36(3): 623-33.
21. Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV. MR microcirculation assessment in cervical cancer: Correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imagg 1999; 10(3): 267-76.
22. Hawighorst H, Weikel W, Knapstein PG, et al. Angiogenic activity of cervical carcinoma: Assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 1998; 4(10): 2305-12.
23. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200(3): 639-49.
24. Barentsz JO, Berger-Hartog O, Witjes JA, et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 1998; 207(3): 791-7.
25. Cao Y, Tsien CI, Shen Z, et al. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol 2005; 23(18): 4127-36.
26. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5(6): 649-55.
27. Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55(2): 329-36.
28. Krix M, Plathow C, Essig M, et al. Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound - initial results. Eur Radiol 2005; 15(4): 677-84.
29. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15(4): 621-28.
30. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magn Reson Med 1994; 32(5): 646-51.
31. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography. Magn Reson Med 1995; 33(4): 506-14.
32. Daniel BL, Yen YF, Glover GH, et al. Breast disease: Dynamic spiral MR imaging. Radiology 1998; 209(2): 499-509.
33. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imag 1999; 10(3): 223-32.
34. Shih TT, Chang CJ, Tseng WY, et al. Effect of calcium channel blockers on vertebral bone marrow perfusion of the lumbar spine. Radiology 2004; 231(1): 24-30.
35. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004; 52(2): 420-9.
36. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001; 56(8): 607-20.
37. Taylor JS, Reddick WE. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. Adv Drug Deliv Rev 2000; 41(1): 91-110.
38. Chen WT, Shih TT, Chen RC, et al. Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: Significance of aging and sex. Radiology 2001; 220(1): 213-8.
39. Chen WT, Shih TT, Chen RC, et al. Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI: In comparison with compression fracture and metastasis. J Magn Reson Imag 2002; 15(3): 308-14.
40. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: Dynamic contrast-enhanced MR imaging -parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192(3): 835-43.
41. Knopp MV, Giesel FL, Marcos H, von Tengg-Kobligk H, Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imag 2001; 12(4): 301-8.
42. Fujita T, Honjo K, Ito K, et al. Dynamic MR follow-up of small hepatocellular carcinoma after percutaneous ethanol injection therapy. J Comput Assist Tomogr 1998; 22(3): 379-86.
43. Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imag 1996; 21(6): 488-94.
44. Tuncbilek N, Karakas HM, Altaner S. Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas. Abdom Imag 2004; 29(2): 166-72.
45. de Vries A, Griebel J, Kremser C, et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: Preliminary results and implications for therapy. Radiology 2000; 217(2): 385-91.
46. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56(4): 958-65.
47. Rubin P, Casarett G. Microcirculation of tumors. II. The supervascularized state of irradiated regressing tumors. Clin Radiol 1966; 17(4): 346-55.
48. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002; 54(3): 759-67.